Elsevier

Toxicology

Volume 208, Issue 2, 15 March 2005, Pages 273-288
Toxicology

Peroxynitrite and drug-dependent toxicity

https://doi.org/10.1016/j.tox.2004.11.023Get rights and content

Abstract

Peroxynitrite is the product of the diffusion-controlled termination reaction between two radicals, nitric oxide and superoxide and is a strong oxidant and nitrating intermediate. Critical biomolecules like proteins, lipids and DNA react with peroxynitrite via direct or radical-mediated mechanisms, resulting in alterations in enzyme activities and signaling pathways. The biological consequences of peroxynitrite-mediated oxidative modifications depend on the levels of oxidant achieved in vivo and its cellular site of production. High and prolonged fluxes of peroxynitrite that overcome the endogenous antioxidant mechanisms, end up in disruption of cell homeostasis leading to apoptotic or necrotic cell death. Several drugs used in modern medicine and agriculture can exert their toxic side effects through mechanisms involving the formation of toxic levels of peroxynitrite, via redox cycling, uncoupling of nitric oxide synthase, stimulation of the endogenous formation of nitric oxide and superoxide or lowering of the antioxidant defenses. Experimental evidence point to peroxynitrite participation in the toxicity of doxorubicin, paraquat, acetaminophen and MPTP (N-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine). The pharmacology against peroxynitrite-mediated toxicity could be oriented towards decreasing the levels of the precursor radicals (i.e. using NOS or oxidases inhibitors, SOD mimetics) or reducing the levels of peroxynitrite itself (peroxynitrite scavengers or decomposition catalysts) and serve to attenuate or neutralize drug-dependent toxicity linked to enhanced peroxynitrite formation.

Introduction

Excess production of the free radicals, nitric oxide (radical dotNO) and superoxide (O2radical dot), is related to cell and tissue pathology (Freeman and Crapo, 1982, White et al., 1994, Beckman and Koppenol, 1996, Radi et al., 2000, Turko and Murad, 2002). Nitric oxide is enzymatically produced from l-arginine by nitric oxide synthase (NOS). Three isoforms of this enzyme have been described: nNOS (neuronal), eNOS (endothelial) and iNOS (induced, inflammatory). On the other hand, superoxide can be catalytically produced (for example, by xanthine oxidase or NADPH oxidase), and also formed by partial reduction of oxygen in the mitochondrial membrane or non-enzymatic monoelectron reduction of oxygen (for example, hemoglobin autoxidation). The termination reaction between radical dotNO and O2radical dot is diffusion-controlled (k = 1010 M−1 s−1) and the product of this reaction is peroxynitrite anion (ONOO). Considering the diffusional properties of the precursor radicals (Lynch and Fridovich, 1978, Denicola et al., 1996b), peroxynitrite1 is predominantly formed close to the site of O2radical dot generation (Chen et al., 1998, Chen and Deen, 2001). Peroxynitrite has a short biological half-life (10–20 ms) but can cross biological membranes and diffuse one to two cell diameters (Denicola et al., 1998). In vivo formation of peroxynitrite is supported by everyday growing experimental evidence (Estevez et al., 1999, Radi et al., 2002, Turko and Murad, 2002, Fries et al., 2003).

Section snippets

Why is peroxynitrite toxic?

Peroxynitrite is not a radical but is a stronger oxidant than its precursor radicals. It is a weak acid, with a pKa of 6.8, therefore, under physiological conditions, both the protonated (ONOOH) and anionic (ONOO) forms are present.

Peroxynitrite can directly react with target biomolecules via one- or two-electron oxidations. These direct reactions are first-order in peroxynitrite and in the target, thus the oxidation is faster at higher concentrations of the target present. The second-order

Toxicology of peroxynitrite

There are several drugs and foreign agents used in modern medicine and agriculture that exert their toxic side effects through mechanisms involving the formation of toxic levels of peroxynitrite. The possible mechanisms are:

  • (a)

    The drug undergoes redox cycling, i.e. it is reduced by a cellular system to yield an intermediate that is then oxidized by O2 to produce O2radical dot, and at the same time and place, a flux of radical dotNO is produced.

  • (b)

    The drug stimulates endogenous production of radical dotNO and O2radical dot (for example,

Pharmacology against peroxynitrite-mediated toxicity

Since peroxynitrite is formed in vivo by reaction of radical dotNO and O2radical dot, any drug that prevents the formation of any of these radicals, will end up in a reduction of peroxynitrite. In this context, inhibitors of NOS, inhibitors of oxidases and/or SOD mimetics could be pharmacologically used (Scheme 3). Another approach could be to reduce the levels of peroxynitrite been form by using peroxynitrite scavengers or decomposition catalysts (Scheme 3). The search for effective pharmacological interventions

Concluding remarks

Peroxynitrite formed in vivo from superoxide and nitric oxide can mediate selective oxidation and nitration of biomolecules via direct or radical-dependent pathways. Depending on the levels and cellular sites of peroxynitrite produced, these oxidative modifications can lead to conformational changes, impaired functions, enzyme inactivation, or signaling pathways alterations, that can overcome the endogenous antioxidant mechanisms and result in disruption of cell homeostasis and potentially

Acknowledgments

This work was supported by grants from Howard Hughes Medical Institute and NIH-FIRCA. RR is an International Research Scholar of the Howard Hughes Medical Institute.

References (180)

  • L. Clejan et al.

    Synergistic interactions between NADPH-cytochrome P-450 reductase, paraquat, and iron in the generation of active oxygen radicals

    Biochem. Pharmacol.

    (1989)
  • P. Costantini et al.

    On the effects of paraquat on isolated mitochondriaEvidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide

    Toxicology

    (1995)
  • S. Cuzzocrea et al.

    Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation

    Free Radic. Biol. Med.

    (1998)
  • B.J. Day et al.

    A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced lung injury in vivo

    Toxicol. Appl. Pharmacol.

    (1996)
  • J.A. DeGray et al.

    Reduction of paraquat and related bipyridylium compounds to free radical metabolites by rat hepatocytes

    Arch. Biochem. Biophys.

    (1991)
  • A. Denicola et al.

    Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations

    Arch. Biochem. Biophys.

    (1996)
  • A. Denicola et al.

    Desferrioxamine inhibition of the hydroxyl radical-like reactivity of peroxynitrite: role of the hydroxamic groups

    Free Radic. Biol. Med.

    (1995)
  • A. Denicola et al.

    Nitric oxide diffusion in membranes determined by fluorescence quenching

    Arch. Biochem. Biophys.

    (1996)
  • J.H. Doroshow et al.

    Redox cycling of anthracyclines by cardiac mitochondriaII. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical

    J. Biol. Chem.

    (1986)
  • G. Ferrer-Sueta et al.

    Reactions of manganese porphyrins with peroxynitrite and carbonate radical anion

    J. Biol. Chem.

    (2003)
  • D.M. Fries et al.

    Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species

    J. Biol. Chem.

    (2003)
  • J. Haendeler et al.

    Effects of redox-related congeners of NO on apoptosis and caspase-3 activity

    Nitric Oxide

    (1997)
  • R.E. Heikkila et al.

    Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity

    Neurosci. Lett.

    (1985)
  • S. Herold

    Nitrotyrosine, dityrosine, and nitrotryptophan formation from metmyoglobin, hydrogen peroxide, and nitrite

    Free Radic. Biol. Med.

    (2004)
  • H. Ischiropoulos

    Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species

    Arch. Biochem. Biophys.

    (1998)
  • H. Ischiropoulos et al.

    Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase

    Arch. Biochem. Biophys.

    (1992)
  • B. Kalyanaraman et al.

    Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs

    Biochim. Biophys. Acta

    (1980)
  • L.K. Klaidman et al.

    Redox cycling of MPP+: evidence for a new mechanism involving hydride transfer with xanthine oxidase, aldehyde dehydrogenase, and lipoamide dehydrogenase

    Free Radic. Biol. Med.

    (1993)
  • B.M. Klebl et al.

    Protein oxidation, tyrosine nitration, and inactivation of sarcoplasmic reticulum Ca2+-ATPase in low-frequency stimulated rabbit muscle

    FEBS Lett.

    (1998)
  • E.A. Konorev et al.

    Rapid and irreversible inhibition of creatine kinase by peroxynitrite

    FEBS Lett.

    (1998)
  • J. Krall et al.

    Superoxide mediates the toxicity of paraquat for cultured mammalian cells

    J. Biol. Chem.

    (1988)
  • D.M. Kuhn et al.

    Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidationCoincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity

    J. Biol. Chem.

    (1999)
  • C.I. Lee et al.

    Regulation of xanthine oxidase by nitric oxide and peroxynitrite

    J. Biol. Chem.

    (2000)
  • R.E. Lynch et al.

    Permeation of the erythrocyte stroma by superoxide radical

    J. Biol. Chem.

    (1978)
  • L.A. MacMillan-Crow et al.

    Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma

    Arch. Biochem. Biophys.

    (2000)
  • A.S. Margolis et al.

    Role of paraquat in the uncoupling of nitric oxide synthase

    Biochim. Biophys. Acta

    (2000)
  • B. Alvarez et al.

    Peroxynitrite reactivity with amino acids and proteins

    Amino Acids

    (2003)
  • B. Alvarez et al.

    Peroxynitrite-dependent tryptophan nitration

    Chem. Res. Toxicol.

    (1996)
  • B.N. Ames et al.

    Oxidants, antioxidants, and the degenerative diseases of aging

    Proc. Natl. Acad. Sci. U.S.A.

    (1993)
  • J. Ara et al.

    Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

    Proc. Natl. Acad. Sci. U.S.A.

    (1998)
  • J.S. Beckman et al.

    Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

    Proc. Natl. Acad. Sci. U.S.A.

    (1990)
  • J.S. Beckman et al.

    Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

    Am. J. Physiol.

    (1996)
  • J.S. Beckman et al.

    Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry

    Biol. Chem. Hoppe Seyler

    (1994)
  • B. Beltran et al.

    The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death

    Proc. Natl. Acad. Sci. U.S.A.

    (2000)
  • H.I. Berisha et al.

    Nitric oxide as a mediator of oxidant lung injury due to paraquat

    Proc. Natl. Acad. Sci. U.S.A.

    (1994)
  • B.S. Berlett et al.

    Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: both modifications mimic effects of adenylylation

    Proc. Natl. Acad. Sci. U.S.A.

    (1998)
  • K. Bian et al.

    The nature of heme/iron-induced protein tyrosine nitration

    Proc. Natl. Acad. Sci. U.S.A.

    (2003)
  • R.H. Blum et al.

    AdriamycinA new anticancer drug with significant clinical activity

    Ann. Intern. Med.

    (1974)
  • C. Brito et al.

    Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death

    J. Immunol.

    (1999)
  • R. Bryk et al.

    Peroxynitrite reductase activity of bacterial peroxiredoxins

    Nature

    (2000)
  • Cited by (122)

    • A fast detection of peroxynitrite in living cells

      2020, Analytica Chimica Acta
      Citation Excerpt :

      It plays a dominant role in cellular signal transduction pathway [3] and antimicrobial activities [4]. However, excessive ONOO− can oxidize multiple target molecules or generate secondary free radicals with highly reactivity [5], resulting in structural modifications and dysfunctions of proteins [6], nucleic acids [7] and lipids [8] with significant cytotoxic consequences. Consequently, the development of sensitive and selective methods for ONOO− is urgently required.

    • Acute acetaminophen intoxication induces direct neurotoxicity in rats manifested as astrogliosis and decreased dopaminergic markers in brain areas associated with locomotor regulation

      2019, Biochemical Pharmacology
      Citation Excerpt :

      Excess generation of NAPQI leads to depletion of hepatocellular GSH pool [16], with the unneutralized NAPQI binding to nucleophilic macromolecules (proteins, DNA and unsaturated lipids) resulting in hepatocellular damage through multi-factorial mechanism(s) [17]. Among the key mechanistic events associated with APAP toxicity, increase in oxidative stress via generation of reactive oxygen species (ROS) [18], glutathione disulfide (GSSG) formation [19,20] and nitric oxide (NO) derivatives generation [21] are seen in association with toxic APAP exposure (for a complete review of APAP toxicity see Du et al. [22]). While APAP administration is safe at therapeutic doses, its excessive use can lead to hepatotoxicity ranging from mild injury to ALF [23].

    View all citing articles on Scopus
    View full text